참고문헌
- Fodor JG, Frohlich JJ. Recommendations for the management and treatment of dyslipidemia. Report of the working group on hypercholesterolemia and other dyslipidemias. CMAJ 2000; 162(10): 1441-1447
- British Cardiac Society, British Hyperlipidemia Association, British Hypertension Society, British Diabetic Association: Joint British recommendations on prevention of coronary heart disease in clinical pratice:summary. BMJ 2000; 320(7236): 705-708 https://doi.org/10.1136/bmj.320.7236.705
- Lamarche B, Moorjani S, Lupien PJ. Apolipoprotein AI and B concentrations and the risk of ischemic heart disease during a 5 year follow up of men in the Quebec cardiovascular study. Circulation 1996; 94(3): 273-278 https://doi.org/10.1161/01.CIR.94.3.273
- Wallius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E, High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infaction (AMORIS study); A prospective study. Lancet 2001; 358(9298); 2026-2033 https://doi.org/10.1016/S0140-6736(01)07098-2
- Talmud PJ, Hawe E, Miller GJ, Humphries SE. Non fasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men. Arterioscler Thromb Vasc Biol 2002; 22(11): 1918-1923 https://doi.org/10.1161/01.ATV.0000035521.22199.C7
- Rahmani M, Raiszadeh F, Allaheverdian S, Kiaii S, Navab M, Azizi F. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxanase enzyme activity in Iranian subjects. Atherosclerosis 2002; 162(2): 381-389 https://doi.org/10.1016/S0021-9150(01)00715-8
- Laker MF, Evans K. Anlysis of apolipoprotein. Ann Clin. Biochem 1996; 33(Pt1): 5-22
- Bhatnagar D, Durrington P. Measurement and Clinical Significance of Apolipoprotein A-I and B, in Rifai N, Warnick GR, Dominiczak M (eds): Handbook of Lipoprotein Testing. Washington, DC, AACC, 1997. pp 177-198
- Colvin P, Parks J. Metabolism of high density lipoprotein subfractions. Curr Opin Lipidol 1999; 10(4): 309-314 https://doi.org/10.1097/00041433-199908000-00004
- Rosseneu M, Fruchart JC, Bard JM. Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects. The EARS study. Circulation 1994; 89(5): 1967- 1973 https://doi.org/10.1161/01.CIR.89.5.1967
- Marcovina SM, Albers JJ, Dati F. International federation of clinical chemistry standardization project for measurement of apolipoproteins A-I and B. Clin Chem 1991; 37(10 Pt1): 1676- 1682
- Leino A, Impivaara O, Kaitaari M, Jarvisalo J. Serum concentrations of apolipoprotein A-I, apolipoprotein B and lipoprotein (a) in a finnish sample. Clin Chem 1995; 41(11): 1633-1636
- Contosis J, McNamara J, Lammi-Keefe C. Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay : Resukts from the Framingham offspring study. Clin Chem 1996; 42(4): 515-523
- Bachorik P, Lovejoy K, Carroll M. Apolipoprotein B and AI distribution in the United States, 1988-1991 : Results of the national health and nutrition examination survey III (NHANES III). Clin Chem 1997; 43(12): 2364-2378
- Jungner I, Marcovina S, Walldius G. Apolipoprotein B and A-I values 1n 147,576 Swedish males and female, standardized according to the World Health Organizationinternational federation of clinical chemistry first international reference materials. Clin Chem 1998; 44(8 Pt1): 1641-1649
- Victoria Valles, Carlos A, Aguilar-Salinas, Francisco J, Gomez-Perez, Rosalba Rojas, Aurora Franco, Gustavo Olaiz, Juan A, Rull, Jaime Sepulveda. Apolipoprotein B and A-I distribution in Mexican urban adults : Results of a nationwide survey. Metabolism 2002; 51(5): 560-568 https://doi.org/10.1053/meta.2002.31977
- Graziani MS, Zanolla L, Righetti G. Plasma apolipoprotein A-I and B in survivors of myocardial infarction and in a control group. Clin Chem 1998; 44(1): 134-140
- Durrington PN, Bolton CH, Hartog M. Serum and lipoprotein apolipoprotein B levels in normal subjects and patients with hyperlipoproteinemia. Clin Chim Acta 1978; 82(1-2): 151-160 https://doi.org/10.1016/0009-8981(78)90038-4
- Sniderman AD, Wolfson C, Teng B. Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and athersclerosis. Ann Intern Med 1982; 97(6) : 833-839 https://doi.org/10.7326/0003-4819-97-6-833
- Sniderman A, Cianflone K. Measurement of apoproteins : Time to improve the diagnosis and treatment of atherrogenic dyslipoproteinemias. Clin Chem 1996; 42(4): 489-491
- Karpe F, Bell M, Bjorkegren J. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl palmitate ester labelling and simulataneous measurements of apolipoprotein B-48 and B-100. Arterioscler Thromb 1995; 15(2): 199-207 https://doi.org/10.1161/01.ATV.15.2.199
- Assmann G, Schulte H. Results and Conclusions of the Prospective Cardiovascular Munster (PROCAM) Study, in Assmann G (ed): Lipid Metabolism Disorders and Coronary Heart Disease. Munich, Germany, MMV Medizin Verlag, 1993. pp 21-67
- Ballantyne C, Grundy SM, Oberman A. Hyperlipidemia : Diagnostic and therapeutic perspectives. J Clin Endocrinol Metab 2000; 85(6): 2089-2112 https://doi.org/10.1210/jc.85.6.2089
- Evans K, Laker MF. Intra-individual factors affecting lipid, lipoprotein and apolipoprotein measurement : A review. Ann Clin Biochem 1995; 32(Pt 3): 261-280 https://doi.org/10.1177/000456329503200303
- Bhopal R, Unwin N, White M, Yallop J, Walwer L, Alberti, Harland J, Patel S, Asmad N, Turner C, Watson B, Kaur D, Kulkarni A, Laker M, Tavridou A. : Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations : Cross sectional study. BMJ 1999; 319(7204): 215-220 https://doi.org/10.1136/bmj.319.7204.215
- Dixon LB, Sudquist J, Kinkleby M. Differences in energy, nutrition and food intakes in a US sample of Mexican American women and men : Finding from the third national health and nutrition examination survey, 1988-1994. Am I Epidemiol 2000; 152(6): 548-557